Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICA GROUP PLC Director's Dealing 2019

Apr 26, 2019

4972_dirs_2019-04-26_e4a7c8df-87d0-4048-a282-f06a6cddfa8d.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1632X

Medica Group PLC

26 April 2019

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 25 April 2019, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR Number of shares subject to option
Dr Stephen Griffith Davies 193,236
Anthony Leonard Lee 135,265
Kevin Patrick Terrins 125,603
Sarah Joanne Burns 125,603
Marc O'Brien 173,913

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.

1. Details of PDMR
(a) Name 1.           Dr Stephen Griffith Davies

2.           Anthony Leonard Lee

3.           Kevin Patrick Terrins

4.           Sarah Joanne Burns

5.           Marc O'Brien
2. Reason for notification
(b) Position / status 1.           Medical Director and Responsible Officer

2.           Chief Financial Officer

3.           Business Development Director

4.           Chief Operating Officer

5.           Chief Technical Officer
(c) Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c) Price(s) and volume Option Price nil in each case

1.           193,236

2.           135,265

3.           125,603

4.           125,603

5.           173,913
(d) Aggregated information N/A
(e) Date of the transaction 25 April 2019
(f) Place of the transaction Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKPDNABKDAQB